Zimbabwe has turned down a major US health deal worth 367 million US dollars (£272m) spanning five years over Washington's insistence on confidential information.
The decision became public after a internal memorandum from December was disclosed, which showed President Emmerson Mnangagwa deemed the agreement was "unbalanced".
A government spokesperson has since stated that the US was seeking genetic material for research and commercial gain but refused to share the benefits from future vaccines.
"We must now begin the challenging and unfortunate task of scaling back our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had donated more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has appealed for continued negotiations to secure a deal agreeable to all parties so the country's vital HIV treatment initiative can continue.
Wider Context
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a high court suspended a similar health funding agreement following concerns were filed about the safety of citizens' health data.
After returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
The agency had overseen aid for the American government, but Trump argued its expenditure was "inefficient" and his administration was seeking government-to-government agreements to enhance openness and accountability.
Based on reports, Sixteen African countries have so far signed these new agreements, representing more than $18.3bn in committed funds.
Details of the Rejected Agreement
This assistance for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this collaboration would have delivered extraordinary benefits for the people of Zimbabwe, especially the 1.2 million presently receiving antiretroviral therapy through American-funded initiatives," Tremont added.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"The proposal required Zimbabwe to share its biological resources and data over an extended period, without any equivalent guarantee of access to any scientific breakthroughs – such as new medicines or tests – that could be developed from that provided information," his statement read.
"Effectively, our country would supply the basic resources for scientific discovery without any assurance that the final treatments would be available to our population should a future pandemic arise."
Sovereignty and Global Health
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting frameworks already established via the international health agency.
The spokesperson cited its Pandemic Benefit-Sharing scheme created to deal with potential global health emergencies.
"This mechanism is designed to ensure that when a nation provides its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the capability to create them."
The government's concerns regarding the US deal "are not meant as anti-American sentiment," he added.
"We encourage further discussions with our US partners on how subsequent co-operation might be designed in a way that honours the independence and interests of both nations."
Health Experts Response
Medical experts expressed it understood the official position, but suggested that talks should continue given that much of the nation's HIV programmes depended on foreign aid.
"In cases where specific concerns arise, including those involving data governance or agreement terms, these can often be addressed through technical clarification and mutually agreed protections," the group commented.
The halted deal highlights the complex debate between accepting crucial international aid and protecting local interests in an increasingly interconnected world.